← Browse by Condition
Medical Condition

plasma cell disorder

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1, Phase 2

ClinicalMetric tracks all active clinical trials for plasma cell disorder sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.

  • Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
  • Phase 1–4 studies from early safety trials to post-marketing surveillance
  • NIH, pharmaceutical sponsor, and academic medical center studies worldwide
  • AI-powered plain-language summary available for every trial listing
Trial Phases
Phase 1
1
Phase 2
1
Top Sponsors
University of Maryland, Baltimore 1 trial
NCT07075510 Phase 1, Phase 2
Recruiting

Subcutaneous Daratumumab Administration in the Thigh Vs Abdomen in Plasma Cell Disorders

Enrollment
30 pts
Location
United States
Sponsor
University of Maryland, Baltim...
View Trial →